*Refresh the page if the below document does not appear.
With Sanofi as its marketing partner, after 36 years long wait Provention Bio’s drug Tzield has been approved by the US regulatory body as the first drug to slow the progression of juvenile diabetes in patients aged 8 years and older.
In a major restructuring move, GSK decided to put a halt to its consumer trade channel affecting almost 200 mid-level employees who were spread out at various places across cities and involved in trade channels.
Aurobindo Pharma announced that the Company’s Unit – IX, an intermediate facility situated at Gundlamachnoor Village, Sangareddy District, Telangana has received 10 observations after an inspection conducted (from 10 – 18 November) by the US health authority.
Dr. Reddy’s Laboratories Ltd. and Cipla Ltd. came to the second and third position in the list of biggest drugmakers by sales in the three months to 30 September after competing with Aurobindo pharma.
On Friday, Sun Pharmaceuticals Ltd. announced that they have received the approval from the US regulatory body for ‘SEZABY’ which is the first and only drug in the US specifically indicated for the treatment of neonatal seizures in term and pre-term neonates.
Life Insurance Corporation of India (LIC) reduced its stake in the large-cap pharma stock in the second quarter of the current financial year (Q2 FY23) from 5.495 to 4.38 per cent. Whereas, mutual funds increased their stake in Sun Pharma for Q2FY23.
Regeneron Pharmaceuticals, Inc. and CytomX
Therapeutics, Inc. have declared a
collaboration and agreement to develop
bispecific cancer therapies using CytomX’s
therapeutic platform and Regeneron’s VelociBi bispecific antibody development platform.
If you don’t already have an account click the button below to create your account.Create New Account